Immunology and Microbiology
T Cell
100%
Mouse
54%
Immunotherapy
49%
Immune Response
43%
T Cell Receptor
36%
Tumor Cell
34%
Cytotoxic T-Cell
32%
Vaccine Efficacy
31%
Dendritic Cell
29%
Regulatory T Cell
28%
Tumor Antigen
24%
CD4
22%
Cytokine
21%
T-Helper Cell
20%
Cancer Immunotherapy
19%
Thymocyte
18%
Antigen Specificity
18%
Granulocyte Macrophage Colony-Stimulating Factor
17%
Colon
17%
Programmed Death-Ligand 1
16%
Vaccination Policy
15%
Immunocompetent Cell
15%
CD8
14%
Interleukin 17
13%
Immune System
13%
Neoantigen
12%
Cancer Cell
12%
Neck
12%
Immune Checkpoint Blockade
12%
Human Papillomavirus Type 16
11%
Tumor Vaccine
11%
Macrophage
10%
Bacteroides fragilis
10%
Immunosuppressive Drug
10%
Myeloid
9%
Squamous Cell
9%
STAT3
9%
Cytotoxic T Cell
9%
Lymphocyte
9%
Transcription Factors
9%
Major Histocompatibility Complex
8%
Prostate
8%
Cancer Vaccine
8%
Tumor Immunity
8%
Gene Expression
8%
Monospecific Antibody
8%
DNA Vaccine
8%
Wild Type
7%
Thymus
7%
Epitope
7%
Keyphrases
Tumor
50%
T Cells
35%
Programmed Death-ligand 1 (PD-L1)
31%
Tumor Immunity
27%
Cancer Immunotherapy
23%
Tumor Cells
22%
CD8+ T Cells
18%
Tumor Antigen
17%
T Cell Receptor
16%
Immune Response
16%
In Cancer
15%
Dendritic Cells
14%
Granulocyte Colony-stimulating Factor (G-CSF)
14%
Immune Checkpoint Blockade
12%
Prostate Cancer
11%
Anti-PD-1
11%
Melanoma
10%
Vaccination
10%
Neoadjuvant
10%
Antitumor Immune Response
10%
Therapeutic Vaccine
10%
Tumor Microenvironment
9%
Thymocytes
9%
Neoantigen
9%
CD4+ T Cells
8%
Interleukin-2
8%
Cancer Therapy
8%
Antigen-specific
7%
Cancer Cells
7%
HPV16
7%
PD-1 Blockade
7%
Immune System
7%
Nivolumab
7%
Colorectal Cancer
7%
Non-small Cell Lung Cancer (NSCLC)
6%
CD-8
6%
Allogeneic
6%
Cancer Vaccine
6%
Glioblastoma
6%
Recombinant
6%
Tumor-specific
6%
Immune Cells
6%
Costimulatory Molecules
6%
Tumor Growth
6%
Anti-tumor Response
6%
DNA Vaccine
6%
Overall Survival
5%
T Cell Activation
5%
Listeria Monocytogenes
5%
Interleukin-4 (IL-4)
5%
Medicine and Dentistry
Neoplasm
73%
Immunotherapy
41%
T Cell
35%
Malignant Neoplasm
34%
Nodular Melanoma
22%
Programmed Death-Ligand 1
19%
Immune Response
19%
Prostate Cancer
15%
Tumor Cell
14%
Tumor Microenvironment
13%
Cytotoxic T-Cell
11%
Cancer Immunotherapy
11%
Immunocompetent Cell
10%
Tumor Antigen
10%
Immune Checkpoint Blockade
10%
Cancer Cell
9%
T-Helper Cell
8%
Non Small Cell Lung Cancer
8%
Nivolumab
8%
Cancer Therapy
8%
Overall Survival
8%
Radiation Therapy
8%
Clinical Trial
7%
Biological Marker
7%
Antigen Specificity
7%
Interferon
7%
Colorectal Cancer
7%
Immune System
7%
Granulocyte Macrophage Colony Stimulating Factor
7%
Lung Cancer
6%
Ganglioglioma
6%
In Vitro
6%
STAT3 Protein
6%
Wart Virus
6%
Specific Tumor
6%
Cytokine
6%
Metastatic Carcinoma
6%
Head and Neck Squamous Cell Carcinoma
6%
Head and Neck Cancer
6%
Disease
5%
Macrophage
5%
Clear Cell Renal Cell Carcinoma
5%
Interleukin 17
5%
CTLA-4
5%
DNA Mismatch Repair
5%
Human Papillomavirus Type 16
5%
Lymphocyte
5%
T Lymphocyte Receptor
5%
Immune Checkpoint Inhibitor
5%
Immunosuppressive Drug
5%
